Interstitial Keratitis
ICD-10 H16.3 · ICD-11 9A78.Z

Treatment of Bacteria-Mediated Interstitial Keratitis (Excluding Syphilitic)

This protocol addresses interstitial keratitis arising from a bacterial cause, specifically in cases where syphilitic aetiology has been excluded. Management combines local ocular therapy with treatment directed at the systemic underlying infection.

Clinical Scenario

Bacteria-mediated interstitial keratitis — excluding syphilitic interstitial keratitis — encompasses a distinct group of cases in which the corneal inflammation is driven by a systemic bacterial process other than syphilis. Addressing the underlying systemic infection is central to achieving resolution; local therapy alone is insufficient.

Treatment Approach (Overview)

Management involves topical corticosteroid therapy directed at the eye for local inflammation control, used alongside systemic antibiotic therapy targeting the causative organism. The full agent selection, sequencing, and dosing criteria are detailed in the complete protocol…

Instant Access to Structured Evidence-Based Regimens

References

Corticosteroids have a role in the local therapy of most forms of bacteria-mediated interstitial keratitis, but all will require specific systemic antibiotics to cure the underlying disease.

With the exception of syphilis, all of the other forms of bacteria-mediated interstitial keratitis benefit from the treatment of the underlying systemic infection.

View source ↗